Omnia M. Elnabawy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Omnia M. Elnabawy has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Sherief
Department of Tropical Medicine, Faculty of Medicine, Ain Shams University Abbasia square, Cairo, Egypt
1 shared publication- Amira Mahmoud Al Balakosy
Ain Shams University, Cairo, Egypt
1 shared publication Azza Hassan
Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Abbasia Square, Cairo, Egypt
1 shared publicationEthar Badran
Department of Tropical Medicine, Faculty of Medicine, Ain Shams University Abbasia square, Cairo, Egypt
1 shared publicationHany Dabbous
Department of Tropical Medicine, Faculty of Medicine, Ain Shams University Abbasia square, Cairo, Egypt
1 shared publication- Hebatallah Ahmed Nasser
Department of Microbiology, Immunology, and Biotechnology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11435, Egypt
1 shared publication
Latest Publications
- 25 August 2021
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
- Vol. 11 (3) , 306-313
Measles IgG Antibodies: Is There a Protective Role in COVID 19 Pandemic?
Background and study aim: Epidemiological data reported lower death rates of COVID-19 cases in countries with higher & recent coverage by measles containing vaccines. In this study we aim to identify measles IgG titer in COVID-19 patients & correlate it with disease severity. Patients and Method: This is a Cross-sectional study where 78 patients admitted to Ain Shams University Quarantine hospitals with positive PCR for SARS-CoV-2 were enrolled. All patients underwent quantification of serum measles IgG titer. Then classified according to the COVID-19 severity into mild, moderate and severe. Results: Measles IgG was positive in 53 patients (68%) with median of 1600 (IQR 1000-or3100), borderline in 18 patients (23%) with median 250 (IQR 200-250) and negative in seven patients (9%) with median 100 (IQR 80-120). Patients with positive measles IgG were significantly older (56±16 years) than those with negative measles IgG ( 48±15 years) (P=0.03).No significant difference was found in measles IgG titer between mild , moderate and severe COVID19 cases. Intensity of pulmonary involvement by CT chest was not correlated with measles IgG titer. The median of measles IgG titer of the ICU admitted patients and those who were not, was 1150 (IQR=600-3500) and 1050 (IQR=200-1800) respectively (p=0.46). No difference in measles IgG titer between patients who recovered or died. Conclusion: Severity of COVID-19 disease and its outcome seem to be unaffected by measles IgG titer.
- 25 August 2021
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
- Vol. 11 (3) , 306-313
Measles IgG Antibodies: Is There a Protective Role in COVID 19 Pandemic?
Background and study aim: Epidemiological data reported lower death rates of COVID-19 cases in countries with higher & recent coverage by measles containing vaccines. In this study we aim to identify measles IgG titer in COVID-19 patients & correlate it with disease severity. Patients and Method: This is a Cross-sectional study where 78 patients admitted to Ain Shams University Quarantine hospitals with positive PCR for SARS-CoV-2 were enrolled. All patients underwent quantification of serum measles IgG titer. Then classified according to the COVID-19 severity into mild, moderate and severe. Results: Measles IgG was positive in 53 patients (68%) with median of 1600 (IQR 1000-or3100), borderline in 18 patients (23%) with median 250 (IQR 200-250) and negative in seven patients (9%) with median 100 (IQR 80-120). Patients with positive measles IgG were significantly older (56±16 years) than those with negative measles IgG ( 48±15 years) (P=0.03).No significant difference was found in measles IgG titer between mild , moderate and severe COVID19 cases. Intensity of pulmonary involvement by CT chest was not correlated with measles IgG titer. The median of measles IgG titer of the ICU admitted patients and those who were not, was 1150 (IQR=600-3500) and 1050 (IQR=200-1800) respectively (p=0.46). No difference in measles IgG titer between patients who recovered or died. Conclusion: Severity of COVID-19 disease and its outcome seem to be unaffected by measles IgG titer.
- 1 March 2019
- Published by Elsevier in Microbial Pathogenesis
- Vol. 128, 13-19
Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens
- 1 March 2019
- Published by Elsevier in Microbial Pathogenesis
- Vol. 128, 13-19
Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens